Assembly Biosciences Inc (ASMB) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Assembly Biosciences Inc   (NASDAQ: ASMB)


Assembly Biosciences Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Assembly Biosciences Inc 's ROA in the second quarter of 2026?
Assembly Biosciences Inc recorded a cumulative net loss of $0 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -0.01%.

However, within the Healthcare sector 212 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2851, from total ROA ranking in the first quarter of 2026 at 3350.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 686.6 % 140.86 % 120.56 % 139.17 % -31.74 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 0 -6 -6 -39 -39
Return On Assets (TTM) -0.01 % -3.15 % -3.64 % -29.02 % -39.68 %
ASMB's Total Ranking # 2851 # 3350 # 3733 # 3925 # 3968
Total Assets (TTM) in million 619 236 258 238 79
Seq. Total Assets Change 162.81 % -8.57 % 8.21 % 202.52 % -19.53 %
Seq. Net Income Change - - - - -

ASMB's 5 Years Annual ROA >> Back to ASMB Management Effectiveness >> Compare ASMB ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 72
Sector # 213
Overall # 2528

Return On Assets Statistics
High Average Low
1.34 %
-45.55 %
-161.54 %
  (Sep 30 2012)



  News about Assembly Biosciences Inc Return on Assets ROA

Assembly Biosciences Secures $12.6M Equity Financing, Empowering Antiviral Innovations and Prolonging Financial Stability

1. Assembly Biosciences Secures $12.6 Million in Equity Financing to Propel Antiviral Portfolio and Extend Cash Runway
Assembly Biosciences, a leading biotechnology company, recently announced the successful completion of equity financings amounting to $12.6 million. The funding is expected to support the advancement of their diverse antiviral portfolio, which includes four candidates currently in clinical development. Moreover, this fresh infusion of capital will extend Assembly Biosciences cash runway into the first quarter of 2026.
The announcement comes at a significant time for Assembly Biosciences, as the company had reported a cumulative net loss of $73 million for the 12-month period ending in the third quarter of 2023. This substantial net loss resulted in a negative return on assets (ROA) of -97.1% during that period. However, the successful equity financings signal a positive shift in the company s trajectory, setting the stage for further growth and advancement.



Financial Statements
Assembly Biosciences Inc 's Assets $ 619 million ASMB's Balance sheet
Assembly Biosciences Inc 's Income $ -4 million Quarterly ASMB's Income Statement
ASMB's Income by Division See ASMB's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 120.56 % -13.6 % 35.57 % -46.48 % -32.43 %
Total Assets in million 258 117 135 100 186
Y / Y Net Income Change - - - - -
Net Income in million -6 -40 -61 -93 -130
Annual Return On Assets -2.38 % -34.4 % -45.3 % -93.36 % -69.7 %

ASMB's 5 Years Annual ROA >> Back to ASMB Management Effectiveness >> Compare ASMB ROA to its Competitors



More Return On Assets Ratios
ASMB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ASMB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ASMB's Competitors
Subscribers only: Roa for Assembly Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for ASMB's Customers

You may also want to know
ASMB's Roi ASMB's Inventory Turnover Ratio ASMB's Growth Rates ASMB's Dividend Comparisons
ASMB's Profitability Ratios ASMB's Asset Turnover Ratio ASMB's Dividend Growth
ASMB's Roe ASMB's Valuation Ratios ASMB's Financial Strength Ratios ASMB's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-03T11:31:14+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.